Pharma Tech

Samsung Biologics: geographic diversification is a sound business decision

Jul 22, 2026, 2:12 PM

Read Full Article → Samsung Biologics: geographic diversification is a sound business decision

Translate article text

Choose a language and wait for the translated text.

Samsung Biologics has been on a steep upward growth trajectory since receiving its first licence to produce biologic drug substances in 2015.